Categoria: Sem categoria

Bedfont’s long-standing UK distributor, Intermedical UK, will be exhibiting their breath analysis medical products at the annual ARTP conference.

A distributor for nearly 10 years, Intermedical UK will be exhibiting the 2nd generation NObreath at the annual Association for Respiratory Technology & Physiology (ARTP) conference and can be found at Stand 25.

FeNO monitoring with the NObreath offers a quick, simple and non-invasive method of assessing airway inflammation for aiding the diagnosis and management of asthma. Interpreting FeNO levels aids in identifying patients who do/do not require on-going treatment(1) whilst also differentiating between allergic (eosinophilic) and non-allergic asthma(2), and if used daily, FeNO measurements can help to predict exacerbations and attacks(3).

New features for the NObreath includes the ability to save patient profiles on the device, Bluetooth connectivity, and SteriTouch technology for optimum infection control. The 2nd generation model also has a fresh and aesthetically pleasing design with a full-colour touchscreen. Furthermore, the NObreath comes with free patient management software allowing the equipment to synchronise with a PC, enabling reports to be generated, data to be backed up, and much more.

Livio Gagliardi, Acting Managing Director at Intermedical, said, “We’re excited to bring the NObreath to ARTP this year. It’s a great opportunity to talk about the benefits of measuring FeNO when monitoring asthma and airway inflammation – especially now it is recommended in the NICE guidance. We believe that the new NObreath will make FeNO monitoring quicker and easier for healthcare professionals and patients alike.”

This year, ARTP is taking place between 31 January and 1st February in Glasgow.

Bedfont Scientific Ltd. is exhibiting its wide range of medical devices at Arab Health 2019, including its new and improved NObreath® FeNO monitor

Breath analysis medical device manufacturer, Bedfont, will be returning to Arab Health 2019 – the largest healthcare exhibition in the Gulf Cooperation Council. They will be exhibiting their wide range of breath analysis medical devices, including the new and improved NObreath FeNO monitor.

The NObreath offers a quick, simple and non-invasive method of measuring FeNO to assess airway inflammation, aiding in the diagnosis and management of asthma. Interpreting FeNO levels aids in identifying patients who do/do not require on-going treatment(1) whilst also differentiating between allergic (eosinophilic) and non-allergic asthma(2), and if used daily, FeNO measurements can help to predict exacerbations and attacks(3).

Alongside a fresh and aesthetically pleasing design with a full colour touchscreen, new features of the 2nd generation NObreath also include the ability to save patient profiles on the device, Bluetooth connectivity, and SteriTouch technology for optimum infection control. Furthermore, the NObreath comes with free patient management software allowing the equipment to synchronise with a PC, enabling reports to be generated, data to be backed up, and much more.

Established in 1976, their other monitors include the Smokerlyzer, used for smoking cessation, and the ToxCO, used by emergency services, to screen for CO poisoning. The Gastrolyzer range aids in the detection of gastrointestinal disorders and food intolerances.

Matthew Skinner, Sales Team Manager, said, “Bedfont aims to continue improving and innovating health, and being the largest healthcare gathering in the GCC, Arab Health is the perfect place to find like-minded companies to work with and help raise awareness of the benefits of breath testing.”

This year, Arab Health is taking place between 28-31 January in Dubai and Bedfont can be found at stand C57, Hall 7.

REFERENCES

1.     Andrew D. Smith, Jan O. Cowan, Sue Filsell, Chris MacLachlan, Gabrielle Monti-Sheehan, Pamela Jackson and D. Robin Taylor. Diagnosing Asthma: Comparisons between Exhaled Nitric Oxide Measurements and Conventional Tests. Am J Respir Crit Care Med Vol 169. pp 473-478, 2004.

2.     Coumou HBel E. Improving the diagnosis of eosinophilic asthma [Internet]. Taylor and Francis online. 2017 [cited 15 March 2017]. Available from: http://www.tandfonline.com/doi/full/10.1080/17476348.2017.1236688

3.     Harkins M. Exhaled Nitric Oxide Predicts Asthma Exacerbation [Internet]. Taylor & Francis. 2017 [cited 21 September 2017]. Available from: http://www.tandfonline.com/doi/abs/10.1081/JAS-120033990

Medical device manufacturer, Bedfont Scientific Ltd., appoints Dr Jafari to the advisory board for its gastrointestinal breath monitoring products

Bedfont, who has specialised in the design and manufacture of breath analysis medical devices for over 40 years, announces today that Dr Jafar Jafari will be the first appointment to its Gastrolyzer Medical Advisory Board.

Head of Upper GI Physiology at the Guy’s and St Thomas’ Foundation Trust Hospitals, Dr Jafari has an MD in Medicine, a PhD in Neurogastroenterology, and has been involved in over 100 research publications regarding gastroenterology. Notably, one of Dr Jafari’s main areas of interest is Hydrogen and C13 GI breath testing.

The Gastrolyzer range works by measuring exhaled levels of hydrogen and methane that are produced when the gut breaks down food; interpreting these gas levels can help to determine gastrointestinal disorders such as lactose intolerance, IBS (Irritable Bowel Syndrome) and more.

Jason Smith, Managing Director, says, “We are privileged to welcome Dr Jafari into our Bedfont Family and onto our Gastrolyzer Medical Advisory Board. We are very fortunate to be able to call upon his extensive knowledge and expertise in the gastrointestinal field.”

Dr Jafar Jafari, adds, “The Gastrolyzer range provides an instant, non-invasive and easy-to-use method for healthcare professionals and patients to use when investigating gut function. I am privileged to have been given this opportunity to contribute to Bedfont’s GI breath testing campaign.”

Bedfont gets into the giving spirit this Christmas with their reverse advent calendar

Christmas is the time for giving, and that’s exactly what the Kent-based company decided to do this year with their reverse advent calendar. A popular idea this year, the reverse advent calendar requires you to put in a gift instead of receiving one and the 2nd generation family business donated their reverse advent calendar to the homeless with the help of their Charity of the Year, Porchlight.

Last year, Porchlight found 834 people sleeping rough in Kent – 5 years ago that number was 148, indicating an alarming 463% increase.

Kate Boulding, Corporate Partnerships Manager at Porchlight, comments, “We are so grateful for the support from Bedfont Scientific Ltd. this year. As well as collecting useful items for their reverse advent calendars and making sure our service users feel valued this Christmas, they have also put loads of effort into their fundraising, which will go towards vital services and help Porchlight bring more homeless and vulnerable people in from the cold. It can be a difficult time of year for the people we support, so with the help of local companies like Bedfont, we can make Christmas a little brighter for them.”

Jason Smith, Managing Director, adds, “The rocketing number of homeless people is a growing concern and through the reverse advent calendar and fundraising for Porchlight, we hope that as a local company we can help give back to the community as well as raise awareness. As our Charity of the Year, we have pledged to raise £3000 for Porchlight; 79% of the rough sleepers Porchlight worked with last year were helped off the streets and so it’s great to know that in supporting Porchlight, the Bedfont Family can really help to make a difference.”

Bedfont gets into the giving spirit this Christmas with their reverse advent calendar

Family business, Bedfont Scientific Ltd., has pledged to row the length of the channel to raise money for local charity, Porchlight.

Earlier this year, Bedfont, based in Harrietsham, announced that all its fundraising was going to its chosen charity of the year. In its latest charity efforts, Bedfont has organised a Big Row on October 11th; Bedfont’s Wellbeing Warriors will set up 2 rowing machines, kindly loaned by Aylesford Sports College, and 2 teams have accepted the challenge to row the length of the Channel, 21 miles, to raise money for Porchlight.

Porchlight, based in Ashford, help people from all walks of life with all types of problems and abilities/disabilities by offering shelter, counselling, advice, skills and more, including a focus on mental health. With a particular focus on helping the homeless, the charity aims to help people solve their issues and overcome their obstacles so that they may live to their full potential.

Niki Carter, Wellbeing Warrior at Bedfont, comments, “We’re taking great strides to improve the health and well-being of our Bedfont family; the Big Row is the perfect opportunity to fundraise for our Charity of the Year as well as provide our employees with a fun and morale raising activity. Please help us towards our £3000 target and donate to support your team by visiting our Virgin Giving Money page.”

To donate to Bedfont’s cause, please visit: https://uk.virginmoneygiving.com/BedfontScientific

Bedfont Scientific Ltd. launches their new and improved FeNO monitor exclusively at the world’s largest European Respiratory Society Congress with a competition to win one.

Medical device manufacturer, Bedfont, who have specialised in breath analysis for over 40 years, have announced a new and improved 2nd generation NObreath®. The FeNO monitor will be launched exclusively at ERS, the world’s largest European Respiratory Society Congress, which takes place this year September 15-19th in Paris.

The 2nd generation FeNO monitor is launched after the recent publication of the NICE guidance on Asthma: diagnosis, monitoring and chronic asthma management, to improve asthma care, which included the NObreath® FeNO monitor from Bedfont as a recommended device[1,2].

To celebrate the exclusive launch, the second-generation family business will also be holding a competition at their stand where delegates will have the chance to be entered into a prize draw to win a new NObreath®.

Jason Smith, Managing Director, comments, “As a breath analysis medical device manufacturer who exports globally, ERS is a key congress for us to reconnect with our customers from around the world. We are thrilled to be launching the 2nd generation NObreath® exclusively at ERS this year as we feel it would be quite symbolic; this launch will bring the product full circle, as the very first NObreath® was too launched at an ERS Congress 11 years ago. We’re excited to show our customers what’s in store for the advancement of respiratory care.” 

REFERENCES

1.     Asthma: diagnosis, monitoring and chronic asthma management | Guidance and guidelines | NICE [Internet]. Nice.org.uk. 2018 [cited 24 April 2018]. Available from: https://www.nice.org.uk/guidance/ng80

2.     Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath | Guidance and guidelines | NICE [Internet]. Nice.org.uk. 2014 [cited 24 April 2018]. Available from: https://www.nice.org.uk/guidance/dg12

Second-generation family business, Bedfont Scientific Ltd., has chosen to dedicate all their fundraising efforts to local charity, Porchlight, for one year

Local medical device manufacturer, Bedfont, has chosen Porchlight to be their Charity of the Year. On Friday 22nd June, the company held a small launch to kick off the fundraising year and reached £75 in one hour alone, making a promising start to their target of £3000 for the year.

The event consisted of a small company picnic with the chance to buy cupcakes and pay to enter miniature competitions, plus a visit from Kate Boulding, Corporate Partnerships Manager at Porchlight, and Alan, someone who had personally been helped by the Charity.

Porchlight, based in Ashford, help people from all walks of life with all types of problems and abilities/disabilities by offering shelter, counselling, advice, skills and more, including a focus on mental health. With a particular focus on helping the homeless, the charity aims to help people solve their issues and overcome their obstacles so that they may live to their full potential.

Jason Smith, Managing Director at Bedfont, comments, “Thanks to the great weather and the excellent support of the Bedfont family at the launch, I have no doubt that we can smash our £3000 target. We have some great fundraising events planned throughout the year and I’m pleased that all proceeds will go to Porchlight to help the homeless around Kent. It was truly an eye-opener to hear Alan’s story and I’m glad that our fundraising efforts will be helping more people get back on their feet.”

Kate Boulding, adds, “When local companies fundraise for Porchlight, it ensures that we can continue helping the most broken and vulnerable people in our society. We are very grateful to Bedfont Scientific for supporting us this year and wish them all the best with their fundraising.”

Breath analysis medical device manufacturer recognised as Technology Business of the Year at the Kent Excellence in Business Awards 2018.

On Thursday 21st June at the Kent Excellence in Business Awards (KEiBA), second-generation family business, Bedfont, was pleased to receive the accolade for Technology Business of the Year 2018. Now in its 10th year, the awards ceremony recognises the achievements of businesses in Kent, with this ceremony being the biggest to date at a record-breaking 320 plus number of entries this year.

Pete Kenyon, Partner at Cripps and Judge for the Technology Business of the Year category, said, “Bedfont impressed the judges on a number of levels. They have taken their knowledge of breath analysis and adapted their products to meet new needs in other medical fields as well as innovating their products throughout the years to meet new demands and markets and to remain current with the ever-changing technology landscape. It is great to see a business in Kent so successfully penetrating global markets and I have no doubt their success story will have many new chapters to follow. 

Jason Smith, Managing Director at Bedfont, comments, “Winning Technology Business of the Year is truly a proud moment for the Bedfont Family. This year, we’ll have been in business for 42 years, and we’ve come such a long way and worked so hard to get breath analysis recognised. According to the UK Business Survey, there are 10,930 businesses in Kent within the professional, scientific and technical sector; so to be recognised as still among those at the forefront of medical technology and innovation today is phenomenal.”

Second-generation family business, Bedfont goes through to the final round of the Kent Excellence in Business Awards for 2 categories

An annual ceremony organised by the KM Group and Kent County Council, the Kent Excellence in Business Awards (KEiBA) recognises companies across Kent and rewards their excellence and achievements. 2018 marks the 10th anniversary of the prestigious KEiBAs and Bedfont Scientific Ltd. is proud to say that it has been named finalists for both Technology Business of the Year and a new category, Family Business of the Year.

Jason Smith, Managing Director, says, “To have been chosen as a finalist in 2 categories is truly an honour, especially as KEiBA received a record-breaking 320 plus number of entries this year. The Bedfont Family works so hard and just to be named as a finalist is great recognition for all they do. We look forward to the awards ceremony in June and wish all finalists in the 16 categories the best of luck.” 

How the world’s first Smokerlyzer® monitor for your smartphone can help you quit smoking.

World No Tobacco Day falls on May 31st every year and encourages smokers to abstain from tobacco for at least 24 hours as a start to kicking the habit. It also aims to raise more awareness of the dangers surrounding tobacco consumption and smoking; statistics published earlier in March from the World Health Organisation (WHO) revealed that tobacco use is directly responsible for over 6 million deaths a year, but even more shockingly, a further 890,000 deaths are those of non-smokers being exposed to second-hand smoke[1]. Whilst there are many methods to help people quit smoking, many studies have shown that carbon monoxide (CO) monitoring has proven to be very effective in monitoring and encouraging a person’s quit attempt and this World Tobacco Day you have the chance to win a personal CO monitor[2].

A study by Beard and West on the effectiveness of personal carbon monoxide monitoring, found that 7/10 people “felt as though the monitors had reduced their cigarette consumption” whilst 6/10 smokers “reported a lower nicotine dependency… over the 6 weeks, there appeared to be a significant decline in the number of cigarettes smoked per day”[3].

The iCO™ is the world’s first Smokerlyzer® CO monitor that connects to your smartphone/tablet. Small, sleek and portable, this personal CO monitor enables you to monitor your CO levels, track your progress and share your results; simply download the app and be motivated to quit smoking, anytime, anywhere. Through a simple, non-invasive breath test this monitor measures the harmful levels of CO in the blood caused by smoking; the more you smoke, the higher the reading but as you start your quit attempt, you can track your readings as they fall.

To be entered into the prize draw, simply visit www.icoquit.co.uk/pages/competition and sign up to the mailing list where you will also receive facts and tips to help you quit smoking.

REFERENCES

1.     Tobacco [Internet]. World Health Organization. 2018 [cited 9 May 2018]. Available from: http://www.who.int/en/news-room/fact-sheets/detail/tobacco

2.     Use of Expired Air Carbon Monoxide Testing in Clinical Tobacco Treatment Settings. Goldstein, Adam O. et al. CHEST , Volume 153 , Issue 2 , 554 – 562

3.     Beard E, West R. Pilot Study of the Use of Personal Carbon Monoxide Monitoring to Achieve Radical Smoking Reduction. Journal of Smoking Cessation. 2012;7(01):12-17.